Tapewire

Nasdaq · USD

APYX

Apyx Medical Corp

Export transactions ↓
Tapewire entity
6609
SEC CIK
0000719135
Parsed reports
138

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 30, 2018 Filed Sep 10, 2018 15:34 UTC GrantStock Option (Option to Buy) · Derivative 24,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0000719135-18-000069 · wf-form4_153659364219494.xml · derivative · entry 1

Waldman Lawrence · CIK 0001516592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2028-08-29

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Read SEC document
August 30, 2018 Filed Sep 10, 2018 15:33 UTC GrantStock Option (Option to Buy) · Derivative 24,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0000719135-18-000067 · wf-form4_153659357019343.xml · derivative · entry 1

Geraghty Michael · CIK 0001516359 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2028-08-29

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Read SEC document
August 30, 2018 Filed Sep 10, 2018 15:33 UTC GrantStock Option (Option to Buy) · Derivative 12,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0000719135-18-000068 · wf-form4_153659360662752.xml · derivative · entry 1

MAKRIDES ANDREW · CIK 0001280517 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2028-08-29

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Read SEC document
August 30, 2018 Filed Sep 10, 2018 15:32 UTC GrantStock Option (Option to Buy) · Derivative 24,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0000719135-18-000066 · wf-form4_153659352678935.xml · derivative · entry 1

Andres John C. · CIK 0001618896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2028-08-29

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Read SEC document
August 30, 2018 Filed Sep 10, 2018 15:31 UTC GrantStock Option (Option to Buy) · Derivative 24,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0000719135-18-000065 · wf-form4_153659348987183.xml · derivative · entry 1

Swandal Craig A. · CIK 0001736883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2028-08-29

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Read SEC document
January 04, 2018 Filed Jan 11, 2018 16:29 UTC
Ewers Jay D.Chief Financial Officer
GrantStock Option (Option to Buy) · Derivative 30,000 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0000719135-18-000004 · wf-form4_151568812504316.xml · derivative · entry 1

Ewers Jay D. · CIK 0001656070 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2028-01-03

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

Read SEC document
September 14, 2017 Filed Sep 27, 2017 13:05 UTC GrantStock Option (Option to Buy) · Derivative 12,000 $0.00 Strike: $2.85 $0.00
Disclosure

SEC source: 0000719135-17-000048 · wf-form4_150651752184882.xml · derivative · entry 1

MAKRIDES ANDREW · CIK 0001280517 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-09-13

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Read SEC document
September 14, 2017 Filed Sep 27, 2017 13:03 UTC GrantStock Option (Option to Buy) · Derivative 12,000 $0.00 Strike: $2.85 $0.00
Disclosure

SEC source: 0000719135-17-000046 · wf-form4_150651740888909.xml · derivative · entry 1

Waldman Lawrence · CIK 0001516592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-09-13

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Read SEC document
September 14, 2017 Filed Sep 27, 2017 13:00 UTC GrantStock Option (Option to Buy) · Derivative 12,000 $0.00 Strike: $2.85 $0.00
Disclosure

SEC source: 0000719135-17-000044 · wf-form4_150651723234414.xml · derivative · entry 1

Geraghty Michael · CIK 0001516359 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-09-13

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Read SEC document
September 14, 2017 Filed Sep 27, 2017 12:59 UTC GrantStock Option (Option to Buy) · Derivative 12,000 $0.00 Strike: $2.85 $0.00
Disclosure

SEC source: 0000719135-17-000042 · wf-form4_150651713746742.xml · derivative · entry 1

Andres John C. · CIK 0001618896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-09-13

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Read SEC document
May 01, 2017 Filed Sep 27, 2017 13:19 UTC
Gershon RobertDirector · Chief Executive Officer
GrantStock Option (Option to Buy) · Derivative 100,000 $0.00 Strike: $3.23 $0.00
Disclosure

SEC source: 0000719135-17-000058 · wf-form4_150651836705440.xml · derivative · entry 1

Gershon Robert · CIK 0001594309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2027-04-30

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

Read SEC document
May 01, 2017 Filed Sep 27, 2017 13:18 UTC
CITRONOWICZ MOSHESr. V.P. of Operations
GrantStock Option (Option to Buy) · Derivative 70,000 $0.00 Strike: $3.23 $0.00
Disclosure

SEC source: 0000719135-17-000057 · wf-form4_150651830246955.xml · derivative · entry 1

CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2027-04-30

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

Read SEC document
May 01, 2017 Filed Sep 27, 2017 13:15 UTC
Ewers Jay D.Chief Financial Officer
GrantStock Option (Option to Buy) · Derivative 70,000 $0.00 Strike: $3.23 $0.00
Disclosure

SEC source: 0000719135-17-000055 · wf-form4_150651808933423.xml · derivative · entry 1

Ewers Jay D. · CIK 0001656070 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2027-04-30

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

Read SEC document
May 01, 2017 Filed Sep 27, 2017 13:11 UTC
SARON J ROBERTDirector · President
GrantStock Option (Option to Buy) · Derivative 70,000 $0.00 Strike: $3.23 $0.00
Disclosure

SEC source: 0000719135-17-000052 · wf-form4_150651786551282.xml · derivative · entry 1

SARON J ROBERT · CIK 0001280854 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2027-04-30

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

Read SEC document
May 01, 2017 Filed Sep 27, 2017 13:07 UTC
McCarthy John J. IIIChief CommercializationOfficer
GrantStock Option (Option to Buy) · Derivative 70,000 $0.00 Strike: $3.23 $0.00
Disclosure

SEC source: 0000719135-17-000050 · wf-form4_150651763508804.xml · derivative · entry 1

McCarthy John J. III · CIK 0001621715 · Chief CommercializationOfficer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2027-04-30

F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.